PNC Financial Services Group’s Procept Biorobotics PRCT Stock Holding History
Bought
Maintained
Sold
Other funds holding PRCT
PNC Financial Services Group's PRCT Position: Q3 2026 in Review
PNC Financial Services Group increased its Procept Biorobotics (PRCT) stake by 6.5% in Q3 2026, buying an estimated $598 and bringing the position to 491 shares worth $8.95K. The position accounts for ﹤0.01% of the portfolio, ranked #4224.
PNC Financial Services Group first reported a position in PRCT in Q2 2022 and has held it in 13 quarters since. The position peaked at $863K in Q2 2022. 225 funds tracked by Wall St. Rank hold PRCT as of Q3 2026.
- PNC Financial Services Group held 491 shares of Procept Biorobotics worth $8.95K as of Q3 2026.
- PNC Financial Services Group bought 30 Procept Biorobotics shares in Q3 2026, an estimated $598.
- Procept Biorobotics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #4224 holding.
- PNC Financial Services Group first reported a position in Procept Biorobotics in Q2 2022 and has held it in 13 quarters since.
- PNC Financial Services Group's Procept Biorobotics position peaked at $863K in Q2 2022.
- 225 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2026.
Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.